Affymax Mulls Bankruptcy After Anemia Drug Recall
Drugmaker Affymax Inc. said Monday that it was laying off 75 percent of its workforce and considering bankruptcy after the recall of its only pharmaceutical product, anemia drug Omontys....To view the full article, register now.
Already a subscriber? Click here to view full article